OCUFEN (Allergan, Inc.)
Welcome to the PulseAid listing for the OCUFEN drug offered from Allergan, Inc.. This Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Allergan, Inc. |
| NON-PROPRIETARY NAME: | flurbiprofen sodium |
| SUBSTANCE NAME: | FLURBIPROFEN SODIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
| ROUTE: | OPHTHALMIC |
| DOSAGE FORM: | SOLUTION/ DROPS |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1987-01-01 |
| END MARKETING DATE: | 0000-00-00 |
OCUFEN HUMAN PRESCRIPTION DRUG Details:
| Item Description | OCUFEN from Allergan, Inc. |
| LABELER NAME: | Allergan, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.3(mg/mL) |
| START MARKETING DATE: | 1987-01-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 11980-801_e41e9af7-b6ef-4c26-bbe9-5ea9e31f45c8 |
| PRODUCT NDC: | 11980-801 |
| APPLICATION NUMBER: | NDA019404 |
Other FLURBIPROFEN SODIUM Pharmaceutical Manufacturers / Labelers:
